ArticleHuman vaccines & immunotherapeutics2014
Regional variations in HPV vaccination among 9-17 year old adolescent females from the BRFSS, 2008-2010.
Article in Human vaccines & immunotherapeutics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.
- Disparities and reverse disparities in HPV vaccination: A systematic review and meta-analysis.Preventive medicine · 2019Pooled it
- State of human papilloma virus vaccine uptake among girls (15-21 years) in Zambia: analysis of a 2024 national survey.Journal of health, population, and nutrition · 2026Article
- Beyond the check-up: how well-child exams, pediatric specialists, and provider recommendations can close HPV vaccine gaps for Chinese American Teens.Cancer causes & control : CCC · 2026Article
- Components of a Digital Storytelling Intervention for Human Papillomavirus and Cancer Prevention Among LGBTQ+ Individuals: Formative Mixed Methods Inquiry.JMIR formative research · 2025Article
- Article
- Socioeconomic and Racial Determinants of Brachytherapy Utilization for Cervical Cancer: Concerns for Widening Disparities.JCO oncology practice · 2021Article
- Geographic Variation in Human Papillomavirus Vaccination Initiation and Completion Among Young Adults in the U.S.American journal of preventive medicine · 2021Article
- HPV-associated oropharyngeal cancer: Knowledge and attitude/beliefs among non-clinical staff at community-based HIV/AIDS Service Organizations (ASO) in the south United States (U.S.) census region.Health & social care in the community · 2020Article
- Geographical disparities in human papillomavirus herd protection.Cancer medicine · 2020Article
- Regional variations in human papillomavirus prevalence across time in NHANES (2003-2014).Vaccine · 2019Article
- Disparities in HPV vaccination rates and HPV prevalence in the United States: a review of the literature.Human vaccines & immunotherapeutics · 2019Review
- Hepatitis C Testing Increased Among Baby Boomers Following The 2012 Change To CDC Testing Recommendations.Health affairs (Project Hope) · 2017Article
- Hypothesis generating data - HPV vaccines - A decade in review.Gynecologic oncology reports · 2017Article
- Missed Opportunities for Human Papillomavirus Vaccination by Parental Nativity, Minnesota, 2015-2018.Public health reports (Washington, D.C. : 1974)Article
- State statutes and regulations related to human papillomavirus vaccination.Human vaccines & immunotherapeuticsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
Abstract
Human papillomavirus (HPV) vaccine uptake among 18-26 y old women varies by geographic region in the US. However, little is known about regional variations in vaccination among girls who are in the vaccine's targeted age groups. Regional variation in HPV vaccination among female adolescents (9-17 y old) was examined using cross-sectional data from the Behavioral Risk Factor Surveillance System (BRFSS) between 2008 and 2010. Multivariable logistic regression estimated the association of region of residence (10 states included questions about adolescent HPV vaccination) with uptake and completion of the 3-shot HPV vaccine series. Among 7,849 adolescents, 26.9% initiated, and 55.2% of initiators completed the series. Adolescents from Northeast/Midwest/West states were 1.74 (95% CI: 1.45-2.10) times more likely to have initiated HPV vaccination compared to the South/Southwestern states. Among initiators, vaccine series completion did not vary significantly between the South/Southwestern and Northeast/Midwest/West states. Flu vaccination was associated with increased odds of initiation in both regions and completion of the HPV vaccine series in the South/Southwestern states only. Girls 9-10 and 11-12 y old were less likely to have initiated and 11-12 y olds were less likely to have completed the HPV vaccine series compared to 13-17 y olds. The observed regional variations in vaccination could cause rates of cervical cancer to remain higher in the South/Southwest and widen currently observed regional disparities in cervical cancer rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.